The presence of HLA-B*5701, -DRB1*0701 and -DQ3 is highly predictive of hypersensitivity to the HIV reverse transcriptase inhibitor abacavir

S. Mallal, C. Witt, A.M. Martin, G. Masel, C. Moore, D. Sayer, A. Castley, C. Mamotte, D. Nolan, I. James, Frank Christiansen

Research output: Chapter in Book/Conference paperConference paper

Original languageEnglish
Title of host publicationXIII International Congress of Histocompatibility and Immunogenetics
EditorsJ. McCluskey
Place of PublicationCopenhagen, Denmark
PublisherBlackwell
Pages33
Volume59, Supplement 2
EditionSeattle, WA, USA
ISBN (Print)00012815
Publication statusPublished - 2002
EventThe presence of HLA-B*5701, -DRB1*0701 and -DQ3 is highly predictive of hypersensitivity to the HIV reverse transcriptase inhibitor abacavir - Seattle, WA, USA
Duration: 1 Jan 2002 → …

Conference

ConferenceThe presence of HLA-B*5701, -DRB1*0701 and -DQ3 is highly predictive of hypersensitivity to the HIV reverse transcriptase inhibitor abacavir
Period1/01/02 → …

Cite this

Mallal, S., Witt, C., Martin, A. M., Masel, G., Moore, C., Sayer, D., Castley, A., Mamotte, C., Nolan, D., James, I., & Christiansen, F. (2002). The presence of HLA-B*5701, -DRB1*0701 and -DQ3 is highly predictive of hypersensitivity to the HIV reverse transcriptase inhibitor abacavir. In J. McCluskey (Ed.), XIII International Congress of Histocompatibility and Immunogenetics (Seattle, WA, USA ed., Vol. 59, Supplement 2, pp. 33). Blackwell.